Literature DB >> 2160434

Disparate mechanisms of induction of procoagulant activity by live and inactivated bacteria and viruses.

S B Sinclair1, O D Rotstein, G A Levy.   

Abstract

This study describes the dose response, time course, and lymphocyte requirements of procoagulant activity (PCA) induction following stimulation of thioglycolate-elicited BALB/c peritoneal macrophages with live and inactivated bacteria (Bacteroides fragilis, Escherichia coli, and Staphylococcus aureus) and murine hepatitis virus type 3 (MHV-3). Induction of PCA by MHV-3 was significantly more rapid and the maximal PCA achieved was significantly greater than by the three bacterial species studied. In relation to induction of PCA by bacteria, the PCA response was more rapid and of greater magnitude with S. aureus and E. coli than with B. fragilis. MHV-3 induced an augmented PCA response at all concentrations of virus studied in a dose-dependent fashion, whereas higher titers of live bacteria (greater than 10(7) CFU/ml) inhibited PCA, suggesting the production of an inhibitory factor. Significant PCA induction was observed when macrophages were incubated with bacteria or virus in the absence of lymphocytes. At low titers of B. fragilis (10(3) CFU/ml), addition of lymphocytes greatly augmented PCA production, whereas at higher titers (10(7) CFU/ml), the addition of lymphocytes only slightly augmented the PCA response. In contrast, MHV-3 induction of PCA was enhanced by the addition of lymphocytes at all concentrations of virus studied, suggesting a lymphocyte-dependent process. Heat-inactivated bacteria were as effective as live bacteria in inducing PCA, suggesting that induction of PCA by bacteria requires only a bacterial surface component. In contrast, UV-inactivated MHV-3 did not induce PCA, suggesting that viral replication is a necessary step in PCA induction. These results suggest that the cellular and metabolic requirements for induction of PCA differ among viral and bacterial pathogens and may partly explain their differences in pathogenicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160434      PMCID: PMC258730          DOI: 10.1128/iai.58.6.1821-1827.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

2.  The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lipopolysaccharide.

Authors:  G A Levy; B S Schwartz; T S Edgington
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

3.  Procoagulant activity of lymphocyte-macrophage populations in rabbits: selective increases in marrow, blood, and spleen cells during Shwartzman reactions.

Authors:  H Rothberger; F B Dove; T K Lee; M P McGee; B Kardon
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

4.  Tissue thromboplastin activity of isolated human monocytes.

Authors:  H Prydz; A C Allison
Journal:  Thromb Haemost       Date:  1978-06-30       Impact factor: 5.249

5.  Lymphocyte collaboration is required for induction of murine monocyte procoagulant activity by immune complexes.

Authors:  B S Schwartz; T S Edgington
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

6.  Stimulation of human leukocyte thromboplastic activity by endotoxin.

Authors:  R G Lerner; R Goldstein; G Cummings; K Lange
Journal:  Proc Soc Exp Biol Med       Date:  1971-10

7.  Effect of purified protein derivative and sonicates of Mycobacterium leprae and Mycobacterium bovis BCG on thromboplastin response in human monocytes in vitro.

Authors:  T Lyberg; O Closs; H Prydz
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Synthesis of thromboplastin by U-937 cells.

Authors:  T Lyberg; K Nilsson; H Prydz
Journal:  Br J Haematol       Date:  1982-08       Impact factor: 6.998

9.  Heparin in the treatment of experimental peritonitis.

Authors:  T Hau; R L Simmons
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

10.  Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man.

Authors:  R B Colvin; R A Johnson; M C Mihm; H F Dvorak
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  6 in total

1.  Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism.

Authors:  D S Kucey; P Y Cheung; O D Rotstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Unilamellar liposomes modulate secretion of tumor necrosis factor by lipopolysaccharide-stimulated macrophages.

Authors:  G F Brisseau; A Kresta; D Schouten; J M Bohnen; P N Shek; E Fok; O D Rotstein
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

3.  Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.

Authors:  R J Fingerote; M Abecassis; M J Phillips; Y S Rao; E H Cole; J Leibowitz; G A Levy
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Peptidoglycan from Staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytes.

Authors:  Eva Mattsson; Heiko Herwald; Lars Björck; Arne Egesten
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Induction of macrophage procoagulant activity by murine hepatitis virus strain 3: role of tyrosine phosphorylation.

Authors:  A P Dackiw; K Zakrzewski; A B Nathens; P Y Cheung; R Fingerote; G A Levy; O D Rotstein
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

6.  Induction of procoagulant activity on human endothelial cells by Streptococcus pneumoniae.

Authors:  S Geelen; C Bhattacharyya; E Tuomanen
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.